Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.
Choudhury AD, Kwak L, Cheung A, Allaire KM, Marquez J, Yang DD, Tripathi A, Kilar JM, Flynn M, Maynard B, Reichel R, Pace AF, Chen BK, Van Allen EM, Kilbridge K, Wei XX, McGregor BA, Pomerantz MM, Bhatt RS, Sweeney CJ, Bubley GJ, Jacene HA, Taplin ME, Huang FW, Harshman LC, Fong L.
Choudhury AD, et al. Among authors: chen bk.
Cancer Immunol Res. 2024 Mar 29:OF1-OF15. doi: 10.1158/2326-6066.CIR-22-0306. Online ahead of print.
Cancer Immunol Res. 2024.
PMID: 38552171